Associations between Socio-Demographic Factors and Hypertension Management during the COVID-19 Pandemic: Preliminary Findings from Malaysia
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Ethical Approval
2.3. Inclusion and Exclusion Criteria
2.4. Sample Size
2.5. Instrument Structure and Translation
- Part 1 (nine items to cover the general socio-demographic details and the average BP reading).
- Part 2 (five statements to assess their health literacy level).
- Part 3 (eight statements to assess their adherence level). This part was developed with permission from the original developer by adopting and adapting Hill–Bone HBP compliance to the high blood pressure therapy scale (HB-HBP) [18].
- Part 4 (eight statements to assess the impact of the pandemic on hypertension control).
2.6. Validity Testing
2.7. Pilot Study and Reliability Testing
2.8. Data Collection
2.9. Statistical Analysis
3. Results
3.1. Demographics of Study Participants and Their Blood Pressure Control
3.2. Health Literacy
3.2.1. Health Literacy (Overall Responses)
3.2.2. Health Literacy (Inferential Statistics)
3.3. Adherence
3.3.1. Adherence (Overall Responses)
3.3.2. Adherence (Inferential Statistics)
3.4. Impact of the COVID-19 Pandemic
3.4.1. Pandemic Impact (Overall Response)
3.4.2. Pandemic Impact (Inferential Statistics)
4. Discussion
4.1. Health Literacy
4.2. Health Literacy and Socio-Demographics
4.3. Adherence
4.4. Adherence & Socio-Demographics
4.5. Pandemic Impact
4.6. Pandemic Impact and Socio-Demographics
4.7. Study Limitations
4.8. Practical Implications and Future Research
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Acknowledgments
Conflicts of Interest
References
- World Health Organization. Hypertension. 2019. Available online: https://www.who.int/news-room/fact-sheets/detail/hypertension (accessed on 12 January 2021).
- Sawicka, K.; Szczyrek, M.; Jastrzębska, I.; Prasał, M.; Zwolak, A.; Daniluk, J. Hypertension—The Silent Killer. J. Pre-Clin. Clin. Res. 2011, 5, 43–46. [Google Scholar]
- Ab Majid, N.L.; Omar, M.A.; Khoo, Y.Y.; Naidu, B.M.; Yn, J.L.M.; Hasani, W.S.R.; Rifin, H.M.; Hamid, H.A.A.; Lourdes, T.G.R.; Yusoff, M.F.M. Prevalence, Awareness, Treatment and Control of hypertension in the Malaysian population: Findings from the National Health and Morbidity Survey 2006–2015. J. Hum. Hypertens. 2018, 32, 617–624. [Google Scholar] [CrossRef]
- Ministry of Health Malaysia. Non-Communicable Diseases: Risk Factors and Other Health Problems; National Health and Morbidity Survey 2019-Technical Report 2019; Volume 1, pp. 1–392. Available online: https://www.researchgate.net/publication/346856736_NHMS_2019_-_Non-Communicable_Diseases_Risk_Factors_and_other_health_problems (accessed on 4 July 2021).
- Hasani, W.S.R.; Ganapathy, S.S.; Lin, C.Z.; Rifin, H.M.; Bahari, M.N.; Ghazali, M.H.; Lodz, N.A.; Ramli, M.H.T.; Ab Majid, N.L.; Ling, M.Y.J.; et al. Comorbidities and clinical features related to severe outcomes among COVID-19 cases in Selangor, Malaysia. West. Pac. Surveill. Response J. WPSAR 2021, 12, 46–52. [Google Scholar] [CrossRef] [PubMed]
- Hashim, J.H.; Adman, M.A.; Hashim, Z.; Radi, M.F.M.; Kwan, S.C. COVID-19 Epidemic in Malaysia: Epidemic Progression, Challenges, and Response. Front. Public Health 2021, 9, 560592. [Google Scholar] [CrossRef] [PubMed]
- Saqlain, M.; Riaz, A.; Malik, M.N.; Khan, S.; Ahmed, A.; Kamran, S.; Ali, H. Medication Adherence and Its Association with Health Literacy and Performance in Activities of Daily Livings among Elderly Hypertensive Patients in Islamabad, Pakistan. Medicina 2019, 55, 163. [Google Scholar] [CrossRef] [Green Version]
- Krousel-Wood, M.A.; Muntner, P.; Islam, T.; Morisky, D.E.; Webber, L.S. Barriers to and Determinants of Medication Adherence in Hypertension Management: Perspective of the Cohort Study of Medication Adherence among Older Adults. Med. Clin. N. Am. 2009, 93, 753–769. [Google Scholar] [CrossRef] [Green Version]
- Shi, D.; Li, J.; Wang, Y.; Wang, S.; Liu, K.; Shi, R.; Zhang, Q.; Chen, X. Association between health literacy and hypertension management in a Chinese community: A retrospective cohort study. Intern. Emerg. Med. 2017, 12, 765–776. [Google Scholar] [CrossRef] [PubMed]
- Magnani, J.W.; Mujahid, M.S.; Aronow, H.D.; Cené, C.W.; Dickson, V.V.; Havranek, E.; Morgenstern, L.B.; Paasche-Orlow, M.K.; Pollak, A.; Willey, J.Z.; et al. Health Literacy and Cardiovascular Disease: Fundamental Relevance to Primary and Secondary Prevention: A Scientific Statement From the American Heart Association. Circulation 2018, 138, e48–e74. [Google Scholar] [CrossRef] [PubMed]
- Jimmy, B.; Jose, J. Patient Medication Adherence: Measures in Daily Practice. Oman Med. J. 2011, 26, 155–159. [Google Scholar] [CrossRef]
- Burnier, M.; Egan, B.M. Adherence in Hypertension. Circ. Res. 2019, 124, 1124–1140. [Google Scholar] [CrossRef]
- Sim, M.R. The COVID-19 pandemic: Major risks to healthcare and other workers on the front line. Occup. Environ. Med. 2020, 77, 281–282. [Google Scholar] [CrossRef] [Green Version]
- Wold Health Organization. WHO the Impact of the COVID-19 Pandemic on Non-Communicable Disease Resources and Services: Results of a Rapid Assessment. Available online: https://www.who.int/teams/noncommunicable-diseases/covid-19%0Ahttps://www.who.int/publications/i/item/ncds-covid-rapid-assessment (accessed on 28 August 2021).
- Elnaem, M.H.; Cheema, E. Caring for patients with diabetes during COVID-19 pandemic: Important considerations for pharmacists. Res. Soc. Adm. Pharm. 2021, 17, 1938–1941. [Google Scholar] [CrossRef]
- Kario, K.; Morisawa, Y.; Sukonthasarn, A.; Turana, Y.; Chia, Y.; Park, S.; Wang, T.; Chen, C.; Tay, J.C.; Li, Y.; et al. COVID-19 and hypertension—Evidence and practical management: Guidance from the HOPE Asia Network. J. Clin. Hypertens. 2020, 22, 1109–1119. [Google Scholar] [CrossRef] [PubMed]
- OMS WHO. Director-General’s Opening Remarks at the Media Briefing on COVID-19—11 March 2020. Available online: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020%0Ahttps://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19 (accessed on 11 March 2020).
- Kim, M.T.; Hill, M.N.; Bone, L.R.; Levine, D.M. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog. Cardiovasc. Nurs. 2000, 15, 90–96. [Google Scholar] [CrossRef] [PubMed]
- Almanasreh, E.; Moles, R.; Chen, T.F. Evaluation of methods used for estimating content validity. Res. Soc. Adm. Pharm. 2019, 15, 214–221. [Google Scholar] [CrossRef] [PubMed]
- Cronbach’s Alpha: Simple Definition, Use and Interpretation—Statistics How to. Available online: https://www.statisticshowto.com/probability-and-statistics/statistics-definitions/cronbachs-alpha-spss/ (accessed on 27 August 2021).
- Harpe, S.E. How to analyse Likert and other rating scale data. Curr. Pharm. Teach. Learn. 2015, 7, 836–850. [Google Scholar] [CrossRef]
- Vargha, A.; Delaney, H.D. The Kruskal-Wallis Test and Stochastic Homogeneity. J. Educ. Behav. Stat. 1998, 23, 170–192. [Google Scholar] [CrossRef]
- Ghaffari-Fam, S.; Sarbazi, E.; Ardabili, F.; Babazadeh, T.; Darghahi, G.; Jafaralilou, H. The role of Health Literacy in Hypertension Control: A cross-sectional study in Iran. Ann. di Ig. Med. Prev. e di Comunita 2020, 32, 263–273. [Google Scholar]
- Malik, A.; Yoshida, Y.; Erkin, T.; Salim, D.; Hamajima, N. Hypertension-Related Knowledge, Practice and Drug Adherence among Inpatients of a Hospital in Samarkand, Uzbekistan. Nagoya J. Med. Sci. 2014, 76, 255–263. [Google Scholar]
- Kilic, M.; Uzunçakmak, T.; Ede, H. The effect of knowledge about hypertension on the control of high blood pressure. Int. J. Cardiovasc. Acad. 2016, 2, 27–32. [Google Scholar] [CrossRef] [Green Version]
- Kreutz, R.; Dobrowolski, P.; Prejbisz, A.; Algharably, E.A.-H.; Bilo, G.; Creutzig, F.; Grassi, G.; Kotsis, V.; Lovic, D.; Lurbe, E.; et al. Lifestyle, psychological, socio-economic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic. J. Hypertens. 2021, 39, 1077–1089. [Google Scholar] [CrossRef]
- Jhaj, R.; Gour, P.R.; Kumari, S.; Sharma, S. Association between medication adherence and blood pressure control in urban hypertensive patients in central India. Int. J. Noncommun. Dis. 2018, 3, 9. [Google Scholar] [CrossRef]
- Li, Y.T.; Wang, H.H.; Liu, K.Q.; Lee, G.K.; Chan, W.M.; Griffiths, S.M.; Chen, R.L. Medication Adherence and Blood Pressure Control Among Hypertensive Patients With Coexisting Long-Term Conditions in Primary Care Settings. Medicina 2016, 95, e3572. [Google Scholar] [CrossRef] [Green Version]
- Matsumura, K.; Arima, H.; Tominaga, M.; Ohtsubo, T.; Sasaguri, T.; Fujii, K.; Fukuhara, M.; Uezono, K.; Morinaga, Y.; Ohta, Y.; et al. Impact of antihypertensive medication adherence on blood pressure control in hypertension: The COMFORT study. QJM Int. J. Med. 2013, 106, 909–914. [Google Scholar] [CrossRef] [Green Version]
- Ramli, A.; Ahmad, N.S.; Paraidathathu, T. Medication adherence among hypertensive patients of primary health clinics in Malaysia. Patient Prefer. Adherence 2012, 6, 613–622. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yusoff, N.H.; Binti, M.; Sook, J.L.W.; Jun, S.M.; Mooi, C.S. Prevalence and factors associated with medication noncompliance among patients with hypertension in a tertiary hospital: A cross-sectional study in Malaysia. Malays. J. Med. Health Sci. 2020, 16, 36–42. [Google Scholar]
- Animut, Y.; Assefa, A.T.; Lemma, D.G. Blood pressure control status and associated factors among adult hypertensive patients on outpatient follow-up at University of Gondar Referral Hospital, northwest Ethiopia: A retrospective follow-up study. Integr. Blood Press. Control 2018, 11, 37–46. [Google Scholar] [CrossRef] [Green Version]
- Menanga, A.; Edie, S.; Nkoke, C.; Boombhi, J.; Musa, A.J.; Mfeukeu, L.K.; Kingue, S. Factors associated with blood pressure control amongst adults with hypertension in Yaounde, Cameroon: A cross-sectional study. Cardiovasc. Diagn. Ther. 2016, 6, 439–445. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nassr, O.A.; Forsyth, P. Evaluation of blood pressure control and associated factors among patients with hypertension in Iraq: A prospective cross-sectional study. J. Pharm. Bioallied Sci. 2019, 11, 232–239. [Google Scholar] [CrossRef]
- Iloh, G.U.P.; Ofoedu, J.N.; Njoku, P.U.; Amadi, A.N.; Godswill-Uko, E.U. Medication adherence and blood pressure control amongst adults with primary hypertension attending a tertiary hospital primary care clinic in Eastern Nigeria. Afr. J. Prim. Health Care Fam. Med. 2013, 5, 1–6. [Google Scholar] [CrossRef] [Green Version]
- Adisa, R.; Ilesanmi, O.A.; Fakeye, T.O. Treatment adherence and blood pressure outcome among hypertensive out-patients in two tertiary hospitals in Sokoto, Northwestern Nigeria. BMC Cardiovasc. Disord. 2018, 18, 194. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pakpour, A.H.; Griffiths, M. The fear of COVID-19 and its role in preventive behaviors. J. Concurr. Disord. 2020, 2, 58–63. [Google Scholar]
- Elnaem, M.H.; Rosley, N.F.F.; Alhifany, A.A.; E Elrggal, M.; Cheema, E. Impact of Pharmacist-Led Interventions on Medication Adherence and Clinical Outcomes in Patients with Hypertension and Hyperlipidemia: A Scoping Review of Published Literature. J. Multidiscip. Health 2020, 13, 635–645. [Google Scholar] [CrossRef] [PubMed]
- Chowdhury, E.K.; on behalf of the Second Australian National Blood Pressure Study Management Committee; Owen, A.; Krum, H.; Wing, L.M.H.; Ryan, P.; Nelson, M.R.; Reid, C.M. Barriers to achieving blood pressure treatment targets in elderly hypertensive individuals. J. Hum. Hypertens. 2013, 27, 545–551. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cordero, A.; Bertomeu-Martínez, V.; Mazón, P.; Fácila, L.; Bertomeu-Gonzalez, V.; Cosin, J.; Galve, E.; Núñez, J.; Lekuona, I.; González-Juanatey, J.R. Factors Associated With Uncontrolled Hypertension in Patients With and Without Cardiovascular Disease. Rev. Española Cardiol. 2011, 64, 587–593. [Google Scholar] [CrossRef] [PubMed]
- Wachholz, P.A.; Masuda, P.Y.; Ferrari, A.C.; Boas, P.J.F.V. Factors related to blood pressure control in a prospective cohort of hypertensive outpatients. Acta Sci. Health Sci. 2016, 38, 57. [Google Scholar] [CrossRef] [Green Version]
- Gee, M.; Bienek, A.; Campbell, N.R.; Bancej, C.M.; Robitaille, C.; Kaczorowski, J.; Joffres, M.; Dai, S.; Gwadry-Sridar, F.; Nolan, R.P. Prevalence of, and Barriers to, Preventive Lifestyle Behaviors in Hypertension (from a National Survey of Canadians With Hypertension). Am. J. Cardiol. 2012, 109, 570–575. [Google Scholar] [CrossRef]
- Liew, S.J.; Lee, J.T.; Tan, C.S.; Koh, C.H.G.; Van Dam, R.; Müller-Riemenschneider, F. Sociodemographic factors in relation to hypertension prevalence, awareness, treatment and control in a multi-ethnic Asian population: A cross-sectional study. BMJ Open 2019, 9, e025869. [Google Scholar] [CrossRef] [Green Version]
- Chmiel, C.; Wang, M.; Senn, O.; Del Prete, V.; Zoller, M.; Rosemann, T.; Steurer-Stey, C. Uncontrolled arterial hypertension in primary care–patient characteristics and associated factors. Swiss Med. Wkly. 2012, 142, w13693. [Google Scholar] [CrossRef] [Green Version]
- Okwuonu, C.G.; Ojimadu, N.; Akemokwe, F.; Okaka, E. Patient-related barriers to hypertension control in a Nigerian population. Int. J. Gen. Med. 2014, 7, 345–353. [Google Scholar] [CrossRef] [Green Version]
- Gobo, G. Sampling, Representativeness and Generalizability. In Qualitative Research Practice; SAGE Publications Ltd.: London, UK, 2011; pp. 405–426. [Google Scholar]
- Khare, S.R.; Vedel, I. Recall bias and reduction measures: An example in primary health care service utilisation. Fam. Pract. 2019, 36, 672–676. [Google Scholar] [CrossRef]
Frequency | Percentage | |
---|---|---|
Age Groups | ||
18–39 | 27 | 18.8 |
40–59 | 99 | 68.8 |
60 or more | 18 | 12.5 |
Gender | ||
Male | 70 | 48.6 |
Female | 74 | 51.4 |
Ethnicity | ||
Malay | 141 | 97.9 |
Chinese | 3 | 2.1 |
Marital status | ||
Unmarried (single/widowed/divorced) | 21 | 14.6 |
Married | 123 | 85.4 |
Level of education | ||
Pre-college education | 37 | 25.7 |
College/University | 107 | 74.3 |
Employment status | ||
Unemployed/retired | 51 | 35.4 |
Employed/Self-employed | 93 | 64.6 |
Monthly household income | ||
Less than RM 4850 (B40 group) | 53 | 36.8 |
RM 4850–RM 10,959 (M40 group) | 64 | 44.4 |
More than RM 10,959 (T20 group) | 27 | 18.8 |
Location of residence | ||
Urban | 121 | 84.0 |
Rural | 23 | 16.0 |
Your average blood pressure reading in the past 7 days | ||
Systolic blood pressure <140 mmHg and diastolic blood pressure <90 mmHg | 111 | 77.1 |
Systolic blood pressure of at least 140 mmHg or diastolic blood pressure of at least 90 mmHg | 33 | 22.9 |
Total | 144 | 100.0 |
Frequency | Percentage | |
---|---|---|
Reading of systolic blood pressure of at least 140 mmHg OR diastolic blood pressure of at least 90 mmHg indicates UNCONTROLLED blood pressure | ||
No, not sure | 37 | 25.7 |
Yes | 107 | 74.3 |
Hypertension is a leading risk factor for cardiovascular diseases. | ||
No, not sure | 14 | 9.7 |
Yes | 130 | 90.3 |
The treatment of hypertension among patients is a lifelong treatment. | ||
No, not sure | 29 | 20.1 |
Yes | 115 | 79.9 |
Reducing the amount of salts intake in diet can reduce blood pressure level. | ||
No, not sure | 32 | 22.2 |
Yes | 112 | 77.8 |
Once a person is diagnosed with hypertension, usually he or she will get cured within few weeks after receiving treatment. | ||
Yes, not sure | 50 | 34.7 |
No | 94 | 65.3 |
Total | 144 | 100.0 |
Frequency | Percentage | |
---|---|---|
How often do you forget to take your hypertension medicine? | ||
Often/very often | 11 | 7.6 |
Sometimes | 28 | 19.4 |
Rarely/never | 105 | 72.9 |
How often do you decide NOT to take your hypertension medicine? | ||
Often/very often | 17 | 11.8 |
Sometimes | 14 | 9.7 |
Rarely/never | 113 | 78.5 |
How often do you eat food rich in salts? | ||
Often/very often | 50 | 34.7 |
Sometimes | 57 | 39.6 |
Rarely/never | 37 | 25.7 |
How often do you eat fast food? | ||
Often/very often | 16 | 11.1 |
Sometimes | 59 | 41.0 |
Rarely/never | 69 | 47.9 |
How often do you miss scheduled appointments with doctor? | ||
Often/very often | 11 | 7.6 |
Sometimes | 17 | 11.8 |
Rarely/never | 116 | 80.6 |
How often do you forget to get prescriptions filled? (Prescription is an official document written by a doctor for the purpose of patient’s medicine supply) | ||
Often/very often | 9 | 6.3 |
Sometimes | 12 | 8.3 |
Rarely/never | 123 | 85.4 |
How often do you skip taking your hypertension pills intentionally when you feel better? | ||
Often/very often | 14 | 9.7 |
Sometimes | 14 | 9.7 |
Rarely/never | 116 | 80.6 |
How often do you miss taking your hypertension pills when you get sick? | ||
Often/very often | 11 | 7.6 |
Sometimes | 13 | 9.0 |
Rarely/never | 120 | 83.3 |
Total | 144 | 100.0 |
Frequency | Percentage | |
---|---|---|
During this pandemic, my blood pressure level becomes worse as compared to before. | ||
Disagree/Strongly disagree | 93 | 64.6 |
Neutral | 37 | 25.7 |
Agree/Strongly agree | 14 | 9.7 |
During this pandemic, I rely more on self-monitoring of blood pressure as compared to before. | ||
Agree/Strongly agree | 66 | 45.8 |
Neutral | 48 | 33.3 |
Disagree/Strongly disagree | 30 | 20.8 |
During this pandemic, I have the fear of going out to get my medications supply due to the risk of COVID-19 infection as compared to before. | ||
Disagree/Strongly disagree | 81 | 56.3 |
Neutral | 31 | 21.5 |
Agree/Strongly agree | 32 | 22.2 |
During this pandemic, my hypertension treatment plan becomes more complex as compared to before. | ||
Disagree/Strongly disagree | 95 | 66.0 |
Neutral | 33 | 22.9 |
Agree/Strongly agree | 16 | 11.1 |
I always practice a healthy diet during this pandemic. | ||
Agree/Strongly agree | 75 | 52.1 |
Neutral | 55 | 38.2 |
Disagree/Strongly disagree | 14 | 9.7 |
Due to this pandemic, I encounter more life-stresses as compared to before. | ||
Disagree/Strongly disagree | 75 | 52.1 |
Neutral | 39 | 27.1 |
Agree/Strongly agree | 30 | 20.8 |
During this pandemic, I seldom attend appointment with doctors as what had been scheduled. | ||
Disagree/Strongly disagree | 94 | 65.3 |
Neutral | 30 | 20.8 |
Agree/Strongly agree | 20 | 13.9 |
I comply with taking the prescribed medications as scheduled during this pandemic. | ||
Agree/Strongly agree | 106 | 73.6 |
Neutral | 25 | 17.4 |
Disagree/Strongly disagree | 13 | 9.0 |
Total | 144 | 100.0 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Elnaem, M.H.; Kamarudin, N.H.; Syed, N.K.; Huri, H.Z.; Dehele, I.S.; Cheema, E. Associations between Socio-Demographic Factors and Hypertension Management during the COVID-19 Pandemic: Preliminary Findings from Malaysia. Int. J. Environ. Res. Public Health 2021, 18, 9306. https://doi.org/10.3390/ijerph18179306
Elnaem MH, Kamarudin NH, Syed NK, Huri HZ, Dehele IS, Cheema E. Associations between Socio-Demographic Factors and Hypertension Management during the COVID-19 Pandemic: Preliminary Findings from Malaysia. International Journal of Environmental Research and Public Health. 2021; 18(17):9306. https://doi.org/10.3390/ijerph18179306
Chicago/Turabian StyleElnaem, Mohamed Hassan, Nur Hasyimah Kamarudin, Nabeel Kashan Syed, Hasniza Zaman Huri, Inderpal Singh Dehele, and Ejaz Cheema. 2021. "Associations between Socio-Demographic Factors and Hypertension Management during the COVID-19 Pandemic: Preliminary Findings from Malaysia" International Journal of Environmental Research and Public Health 18, no. 17: 9306. https://doi.org/10.3390/ijerph18179306
APA StyleElnaem, M. H., Kamarudin, N. H., Syed, N. K., Huri, H. Z., Dehele, I. S., & Cheema, E. (2021). Associations between Socio-Demographic Factors and Hypertension Management during the COVID-19 Pandemic: Preliminary Findings from Malaysia. International Journal of Environmental Research and Public Health, 18(17), 9306. https://doi.org/10.3390/ijerph18179306